Lifebit

What Lifebit does

Lifebit is a London-based health data intelligence company that builds a federated Trusted Research Environment (TRE) platform enabling secure analysis of biomedical and genomic data without moving it from its source location. The platform brings compute to the data rather than centralizing data into a vendor cloud, enforcing GDPR, HIPAA, FedRAMP, ISO 27001, and SOC 2 compliance architecturally and supporting population-scale genomic research across sovereign jurisdictions. The modular product suite includes the core TRE, Trusted TargetID, Trusted Clinical Environment, Trusted Data Lakehouse, Trusted Data Factory, Trusted Data Hub, AI-Automated Airlock, Lifebit R.E.A.L. (pharmacovigilance), and the recently launched Version 4 Agentic Federated Platform, which enables researchers to perform the full research lifecycle through a natural language AI interface.

Lifebit serves government health agencies (Genomics England, NIH, Singapore MOH, CanPath), commercial pharmaceutical companies (Boehringer Ingelheim, Flatiron Health, 23andMe, United Health Group), and nonprofit research organizations (Lupus Research Alliance, Cancer Research Horizons). Named deployments collectively cover 275M+ patient records across 30+ countries, including 50 petabytes of Genomics England data, 100,000 Singaporean participants, and 5M+ Flatiron Health oncology records. Distribution occurs through direct enterprise sales, AWS Marketplace, and the UK Crown Commercial Services framework, with a free TRE START tier targeting small research teams.

The company operates a subscription-based licensing model with custom enterprise pricing, supported by an enterprise field sales motion targeting C-suite and research leadership. Lifebit has raised approximately $70.6M across seed through Series B rounds, with the September 2021 $60M Series B led by Tiger Global Management. The founding team includes CEO Maria Chatzou Dunford, CTO Pablo Barja, Chief Business Development Officer Thorben Seeger, and Chief Growth Officer Nate Raine. Lifebit is incorporated as Lifebit Biotech Limited in England and Wales, with US operations via Lifebit Biotech Inc. and an R&D centre in Singapore.

Name

Lifebit

Legal name

Lifebit Biotech Limited

Website

https://lifebit.ai

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

51–100 employees

Short description

Lifebit provides a federated Trusted Research Environment platform that enables secure, in-situ analysis of biomedical and genomic data without data movement, serving government health agencies, pharmaceutical companies, and research nonprofits across 30+ countries.

Ownership category

akta.pro rank

Product category

Biomedical Data Analytics Software

NAICS

Software Publishers (5132), Computer Systems Design and Related Services (54151)

SIC

Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

Scientific Data Management & Data Platforms (SDMS/Data Lakehouse for R&D) (HLAGAJAC)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Cloud Security (CSPM/CWPP/CIEM) for Health IT (HLACAJAG)

Keywords

• Federated data analytics
• Biomedical research software
• Genomic data platform
• Trusted research environment
• Health data infrastructure

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Operations

Revenue model

1. Platform Subscription and Licensing: Lifebit generates revenue primarily through subscription-based licensing of its federated Trusted Research Environment platform. The platform is deployed within customers' own cloud environments (not Lifebit's), with customers paying for access to the analytics infrastructure, security features, and governance tools. Pricing includes tiered plans with a free tier (TRE START) for small research teams and non-profits, as well as paid enterprise plans. Revenue is recurring in nature as customers maintain ongoing subscriptions for platform access and support.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Core offering

Lifebit builds and licenses a federated Trusted Research Environment (TRE) platform (CloudOS) that enables secure, in-situ analysis of distributed biomedical and genomic data without moving it from source locations. The platform is deployed inside customers' own cloud environments and is sold via enterprise subscription, with a free TRE START tier, and includes modular components for target identification, clinical interpretation, data harmonization, federated querying, security/governance, and adverse drug reaction surveillance.

Product overview

Lifebit offers a federated Trusted Research Environment (TRE) platform with a modular architecture designed for secure, in-situ analysis of distributed biomedical data without data movement. The core platform comprises the Trusted Research Environment as the primary product, supplemented by specialized modules including Trusted TargetID (drug target identification), Trusted Clinical Environment (clinical analysis), Trusted Data Lakehouse (data cataloging), Trusted Data Factory (OMOP mapping/harmonization), Trusted Data Hub (federated querying), Trusted Data Marketplace (access to 275M+ patient records), and Lifebit R.E.A.L. (adverse drug reaction surveillance). Security and governance modules include Airlock/AI-Automated Airlock (data export controls), Security Posture Management, System Health Observability, Security Tower, and Trusted Operational Governance. The Agentic Federated Platform (Version 4) represents the latest major release, introducing conversational AI capabilities. TRE START provides a free tier for small teams, while Rapid Data Products enables instant access to curated datasets.

Differentiator

Problem solved

Functional benefit

Products and services

• Trusted Research Environment (TRE) The world's #1 federated Trusted Research Environment enabling secure, in-situ analysis of distributed biomedical data without data movement, supporting population-scale genomics and health data research across sovereign jurisdictions. For government, pharma, health nonprofit, and health system customers.
• Trusted TargetID AI-powered drug target identification and validation module within the TRE, enabling researchers to turn biomedical data into validated drug targets through federated analysis. For pharmaceutical R&D and translational informatics teams.
• Trusted Clinical Environment Specialized TRE for clinical data analysis, turning data into clinical actions and supporting clinical interpretation and healthcare decision-making. For health systems and clinical research teams.
• Lifebit R.E.A.L. Real-time drug side effects and disease outbreak surveillance platform for pharmacovigilance and public health monitoring. For pharma, public health agencies, and government health bodies.
• Trusted Data Lakehouse Federated data automation module for connecting and cataloging distributed biomedical data assets at scale, providing data infrastructure for health and genomic data management. For pharma, government, and data provider customers.
• Trusted Data Factory AI-powered data transformation and harmonization tool that maps distributed data to OMOP and other standards, making data usable for federated analysis. For enterprise research data teams and government health agencies.
• AI-Automated Airlock AI-powered governance solution for secure biomedical data exports with real-time RAG risk decisioning and governed workflows, automating compliance without manual review. Trusted by institutions managing over 275 million patient records. Available via AWS Marketplace for cloud-native procurement.
• Trusted Data Marketplace Data marketplace providing access to federated patient data from 275M+ patients across 30+ countries for research and drug discovery. For pharmaceutical and biotech customers seeking cohort access.
• Rapid Data Products Instant access to deeply curated, multimodal real-world data for medical research, allowing teams to quickly browse, select, and analyze disease cohorts across therapeutic areas including Cardiometabolic, CNS, and Inflammatory. For pharma R&D teams.
• Agentic Federated Platform (Version 4) Version 4 of Lifebit's platform, claimed as the world's first fully agentic Trusted Research Environment, enabling researchers to perform the entire research lifecycle from data harmonization to results interpretation through a conversational natural-language AI interface. For enterprise research teams and government agencies.
• TRE START Free tier of the Trusted Research Environment allowing small research teams and non-profits to deploy secure, compliant research environments directly in their cloud accounts with rapid setup and integration. For small research teams, academic labs, and budget-constrained non-profits.
• Trusted Operational Governance Comprehensive governance solution providing role-based access, policy enforcement, and complete audit trails for every action, user, and system across federated environments. For enterprise compliance, security, and IT teams.

Quantifiable outcome

• 90% faster target identification and validation for pharmaceutical companies
• +7 more outcomes

Named customers11 records

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability8 records

Feature14 records

Partnerships

15 partnerships are on record, tiered core, minor and flagship.

• Lung Cancer Genetics StudycoreStrategic or Co-development Partner · 8 September 2025Lung Cancer Genetics Study launched by 23andMe, Troper Wojcicki Philanthropies, and Lifebit. Open-source data platform provides researchers access to de-identified genetic and health data for lung cancer research. Study has enrolled 1,200+ participants targeting 10,000 by 2027.
• 23andMecoreStrategic or Co-development Partner · 6 September 2025Partnership for the Lung Cancer Genetics Study open-source data platform, launched by 23andMe Research Institute, Troper Wojcicki Philanthropies, and Lifebit. Lifebit's TRE enables qualified researchers to access de-identified genetic and health data at no cost.
• Troper Wojcicki PhilanthropiesminorStrategic or Co-development Partner · 6 September 2025Funding partner for the Lung Cancer Genetics Study, collaborating with 23andMe and Lifebit to advance lung cancer genetics research with an open-source data platform.
• Cancer Research HorizonscoreStrategic or Co-development Partner · 30 January 2025Partnership to maximise the impact of research data through federated analysis capabilities, enabling Cancer Research Horizons to leverage Lifebit's secure research environment.
• PsifasminorStrategic or Co-development Partner · 24 January 2025Partnership to advance genomic research in Israel through Lifebit's federated platform capabilities.
• Flatiron HealthcoreStrategic or Co-development Partner · 31 May 2023Multi-year strategic partnership announced May 31, 2023 to support vital cancer research enabling scientific discoveries. Lifebit's federated TRE enables approved researchers to safely access Flatiron's high-quality real-world oncology data for breakthrough analysis globally. Flatiron has international presence across UK, Germany, US and Japan.
• Lupus Research AlliancecoreStrategic or Co-development PartnerLupus Research Alliance's DREAM platform runs on Lifebit's federated TRE, uniting molecular and clinico-phenotypic data across 9+ CROs in US and Canada for lupus research without data movement.
• Genomics EnglandflagshipStrategic or Co-development PartnerGenomics England Research Environment powered by Lifebit's federated TRE, supporting the 100,000 Genomes Project, National Genomic Research Library, and Generation Study with 5,000+ researchers.
• NIH / NLMflagshipStrategic or Co-development PartnerFirst federated platform deployed at NIH, connecting 8 Institutes/Centers with 19 pan-IC datasets mapped to OMOP CDM for unified, federated discovery across NIH research assets.
• Synapxe (Singapore)flagshipStrategic or Co-development PartnerCollaboration with Singapore's national HealthTech agency for the TRUST platform (Singapore's Trusted Research and Real-World Data Discovery Platform). Lifebit opened an R&D centre in Singapore to support this national initiative.
• CanPath / Genome CanadacoreStrategic or Co-development PartnerCanPath's 350,000-participant dataset accessible through Lifebit's federated TRE with pan-Canadian regulatory compliance across diverse provincial requirements.
• Boehringer IngelheimcoreStrategic or Co-development PartnerAnalytics platform deployed inside Boehringer Ingelheim's own cloud environment for translational research, enabling federated analysis across UK Biobank, Genomics England, and internal clinical data. Partnership includes outbreak detection on real-world data using Lifebit R.E.A.L.
• Flatiron HealthcoreStrategic or Co-development PartnerPartnership to advance cancer care in Japan through real-world data analysis using Lifebit's federated platform.
• AWS MarketplacecoreChannel Partner/ Reseller/ DistributorAI-Automated Airlock product available for rapid procurement via AWS Marketplace, enabling cloud-native customers to deploy compliant data export controls at scale.
• SynapxeflagshipStrategic or Co-development PartnerR&D centre opened in Singapore in collaboration with Synapxe to support Singapore's National Precision Medicine programme and TRUST platform operations.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• DNAnexus: DNAnexus provides a cloud-based biomedical informatics platform for genomics and clinical data, directly competing with Lifebit's Trusted Research Environment in pharma, government, and diagnostics use cases. Both target federated analysis of large-scale genomic and clinical data.
• BC Platforms: BC Platforms offers a genomic data platform with federated access to biobanks and real-world data for pharma R&D, overlapping directly with Lifebit's Trusted Data Marketplace and TRE capabilities across European and global pharma customers.
• Velsera (formerly Seven Bridges): Velsera provides a genomics and multi-omics data analysis platform serving pharma, academic, and clinical customers, directly competing with Lifebit on cloud-based biomedical analysis, federated workflows, and clinical interpretation tools.
• Datavant: Datavant specializes in health data connectivity, de-identification, and privacy-preserving record linkage, addressing the same federated, secure data-sharing problems Lifebit solves for biomedical research, with overlap in life sciences and government health customers.

Broad incumbents

• Palantir Foundry: Palantir's Foundry platform is used by major government health agencies and large pharma companies for data integration and analytics. While broader in scope, it competes with Lifebit for the same institutional budgets around health data integration and analytics.
• Verily (Alphabet): Verily operates a broad health data platform spanning real-world evidence, clinical research, and precision medicine, overlapping with Lifebit in pharma R&D and national health initiatives. It benefits from Alphabet-scale infrastructure and competes for similar large customer budgets.
• IQVIA (E360 / Orchestrated Patient Insights): IQVIA is a dominant clinical and real-world data provider with a healthcare analytics platform serving pharma. It is a broad incumbent competing for the same pharma R&D and health system analytics budgets that Lifebit addresses with its federated TRE.

Emerging players

• Owkin: Owkin applies federated AI to biomedical research, particularly in oncology, directly overlapping with Lifebit's federated learning and pharma R&D positioning. Both target pharma customers seeking privacy-preserving access to distributed hospital data.
• Seqera Labs: Seqera provides Nextflow-based workflow orchestration widely used in genomics and life sciences research, with overlap in cloud-based scientific data analysis. While more focused on workflow orchestration than full TRE, Seqera is increasingly used in similar biomedical research pipelines.
• TripleBlind: TripleBlind provides privacy-preserving computation APIs for healthcare and life sciences, addressing similar federated data access problems as Lifebit, though at an earlier stage and with a more API-oriented product rather than a full TRE.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/lifebitAI
• GitHubgithub.com/lifebit-ai
• YouTubeyoutube.com/channel/UCZD4p-fsOh6AUgRvMl1RNfQ
• LinkedInlinkedin.com/company/lifebit-ai

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lifebit